Logo

CuraGen, Genentech Extend Drug Discovery Collaboration

Apr 20, 2000
Premium

NEW HAVEN, Conn.--CuraGen and Genentech announced that their drug research collaboration will continue for at least two-and-a-half-years. The deal, struck up in 1997, applies CuraGen's high-throughput functional genomic technologies and disease expertise to discovery of protein therapeutics and antibodies.

Filed under

Informatics
Breaking News
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.